Trials / Completed
CompletedNCT03205072
POCS in Liver Transplantation Patients
Per-Oral Cholangioscopy in Liver Transplantation Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 42 (actual)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A prospective, multi-center, non-randomized, observational, consecutive case series, which will compare Endoscopic Retrograde Cholangiopancreatoscopy (ERCP) and cholangioscopy with Spy Glass Digital System (DS) procedure at 5-10 centers.
Detailed description
The objective of this study is to demonstrate the clinical utility of cholangioscopy with Spy Glass Digital System (DS) in cadaveric donor or live donor liver transplantation patients who are referred for ERCP in the setting of a clinical suspicion of post liver transplant bile duct stricture(s). A secondary study objective is to generate a hypothesis for a randomized controlled trial comparing ERCP alone to ERCP with Per- Oral Cholangioscopy (POCS) in patients referred for ERCP post liver transplantation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Spy Glass DS | The SpyScope™ DS Access and Delivery Catheter (SpyScope™ DS Catheter) is a sterile, single-use endoscope that enables access and delivery of accessories to targeted pancreaticobiliary anatomy and displays live video when connected to a Spy Glass DS Digital Controller. |
Timeline
- Start date
- 2018-01-25
- Primary completion
- 2022-03-24
- Completion
- 2022-03-24
- First posted
- 2017-07-02
- Last updated
- 2022-07-28
Locations
5 sites across 4 countries: United States, Brazil, Netherlands, Spain
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03205072. Inclusion in this directory is not an endorsement.